Speakers in the News

Europe’s ‘Hamilton Moment’ Is a Flop. That’s Fine.

(Bloomberg Opinion) - Federalizing debt was what united the states, but don't expect the same effect from a European Recovery Fund.

Behind the HHS-CDC Disagreement

(The Wall Street Journal) - An interagency feud over key data demonstrates the inadequacy of U.S. efforts to prepare for a pandemic.

An American in Paris: NSC Chief O’Brien presses U.S. interests in French capital

(FOX) – O'Brien rekindled old friendships, asserted US interests, and made life increasingly miserable for an emerging adversary

Back to school or back to square one?

(CNN) - Even though the heat of mid-summer is still upon us and the coronvirus pandemic continues, back-to-school season is right around the corner. With…

Ivanka Trump’s tone-deaf Tuesday

(CNN) - Ivanka Trump had quite a day on Tuesday. She started it as the face of one of the most tone-deaf campaigns the White…

Universal Masking to Prevent SARS-CoV-2 Transmission—The Time Is Now

(JAMA) – Public health officials and leaders need to ensure that the public understands clearly when and how to wear cloth face coverings properly and…

The Justices’ Wakeup Call to Congress

(WSJ) – When it created the CFPB, the legislature gave it immense power. Now, the presidency has a hold of it.

Schools Can Open Safely This Fall

(Wall Street Journal) - Staggered schedules and other precautions would help reduce children’s low but real risk from Covid.

Lessons from dual pandemics

(Merck) – A conversation with Merck Chief Patient Officer Julie Gerberding, M.D., M.P.H., about her early work caring for people with HIV and AIDS, and…

America and China Are Entering the Dark Forest

(Bloomberg Opinion) - To know what the Chinese are really up to, read the futuristic novels of Liu Cixin.

If the United States were my patient: We aren’t ready to celebrate yet

(CNN) - Seven weeks later, as we approach the patient's birthday -- July 4th -- I thought it would be a good time to check…

Antibodies Can Be the Bridge to a Vaccine

(The Wall Street Journal) - Drugs that mimic an immune response are in development, but it’s time to ramp up manufacturing.